Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sputum smear conversion during directly observed treatment for tuberculosis

H L Rieder1

  • 1International Union Against Tuberculosis and Lung Disease, Paris, France.

Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|April 1, 1996
PubMed
Summary

Tuberculosis treatment in a refugee camp showed 75% sputum smear conversion after two months. A positive smear at two months strongly predicted treatment failure, indicating potential benefit from extended intensive phases for some patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Armand Van Deun - pioneering public health physician (1953-2023).

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2024
Same author

When to start treatment? Dilemma illustrated by a paediatric case of extensively drug-resistant tuberculosis of the central nervous system.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2020
Same author

Gatifloxacin is superior to levofloxacin and moxifloxacin in shorter treatment regimens for multidrug-resistant TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019
Same author

Outcome definitions for multidrug-resistant tuberculosis treated with shorter treatment regimens.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019
Same author

Sputum smear microscopy in the Xpert<sup>®</sup> MTB/RIF era.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2018
Same author

Principles for constructing a tuberculosis treatment regimen: the role and definition of core and companion drugs.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2018

Area of Science:

  • Public Health
  • Infectious Diseases
  • Tuberculosis Research

Background:

  • Tuberculosis (TB) remains a significant global health challenge, particularly in resource-limited settings like refugee camps.
  • Effective treatment programs and monitoring are crucial for TB control and preventing drug resistance.

Purpose of the Study:

  • To assess sputum smear conversion rates during TB treatment in a Thai refugee camp.
  • To identify predictors of treatment failure, specifically failure to achieve sputum smear conversion.

Main Methods:

  • A cohort study analyzed sputum smear conversion using direct microscopy monthly.
  • A nested case-control study compared patients who failed to convert with those who did.
  • Patients received a directly observed daily regimen including rifampicin.

Related Experiment Videos

Main Results:

  • Sputum smear conversion was 75.0% after the 2-month intensive phase.
  • Initial smear positivity influenced conversion rates (61.7% to 90.9%).
  • A positive sputum smear at 2 months was the strongest predictor of no definitive conversion within 4 months (aOR 4.2).

Conclusions:

  • Strict sputum examination may indicate slower conversion than routine programs, but late positive results can be isolated.
  • Early sputum smear results (at 2 months) are strong predictors of later bacteriologic outcomes.
  • Identifying patients with persistent positive smears at 2 months could guide treatment intensification or extension.